Respiratory Tract Disease

Respiratory·MeSH: Respiratory Tract Diseases

22 drugs in development·3 companies·3 clinical trials

Drug Pipeline by Phase

Approved(2)

Drug	Company
enflonsia	Merck & Co., Inc. (MRK)
mRESVIA	Moderna, Inc. (MRNA)

Phase 3(9)

Drug	Company
hexyon vaccine	Sanofi (SNY)
m-m-rvaxpro vaccine	Sanofi (SNY)
menac conjugate vaccine	Sanofi (SNY)
menacyw135 polysaccharide vaccine	Sanofi (SNY)
sars-cov-2 adjuvanted recombinant protein vaccine	Sanofi (SNY)
trivalent recombinant influenza vaccine	Sanofi (SNY)
varivax vaccine	Sanofi (SNY)
vaxneuvance vaccine	Sanofi (SNY)
yellow fever vaccine	Sanofi (SNY)

Phase 2(3)

Phase 1(1)

Drug	Company
trivalent vaccine candidate	Sanofi (SNY)

Phase 1/Phase 2(7)

Drug	Company
chlamydia mrna vaccine	Sanofi (SNY)
quadrivalent influenza standard dose vaccine	Sanofi (SNY)
rsv/hmpv vaccine candidate dose a	Sanofi (SNY)
rsv/hmpv vaccine candidate dose b	Sanofi (SNY)
rsv/hmpv vaccine candidate dose l	Sanofi (SNY)
tiv mrna-ha vaccine 2	Sanofi (SNY)
trivalent messenger ribonucleic acid hemagglutinin vaccine 1	Sanofi (SNY)

BioSniper tracks 22 drugs in development for Respiratory Tract Disease across 3 companies.

There are 3 clinical trials targeting Respiratory Tract Disease tracked by BioSniper.

Full trial data, competitive analysis, and AI-powered pipeline tracking.